IRIS UniCatt

Barone, Carlo Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.285
NA - Nord America 2.970
AS - Asia 2.071
SA - Sud America 404
AF - Africa 73
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.815
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.895
DE - Germania 1.475
SG - Singapore 953
CN - Cina 585
SE - Svezia 427
BR - Brasile 334
IT - Italia 265
PL - Polonia 234
UA - Ucraina 182
GB - Regno Unito 172
FR - Francia 125
VN - Vietnam 118
IE - Irlanda 106
IN - India 105
FI - Finlandia 71
ID - Indonesia 70
RU - Federazione Russa 68
TR - Turchia 44
CA - Canada 36
JP - Giappone 34
BE - Belgio 33
HK - Hong Kong 33
AR - Argentina 30
MX - Messico 28
NL - Olanda 28
ZA - Sudafrica 26
BD - Bangladesh 24
CI - Costa d'Avorio 22
ES - Italia 21
IR - Iran 20
IQ - Iraq 17
EC - Ecuador 15
AT - Austria 14
LT - Lituania 14
KR - Corea 13
RO - Romania 12
MA - Marocco 8
PK - Pakistan 8
AE - Emirati Arabi Uniti 6
AU - Australia 6
CZ - Repubblica Ceca 6
RS - Serbia 6
SA - Arabia Saudita 6
VE - Venezuela 6
CL - Cile 5
CO - Colombia 5
JO - Giordania 5
UZ - Uzbekistan 5
CH - Svizzera 4
KE - Kenya 4
PE - Perù 4
PT - Portogallo 4
SN - Senegal 4
BG - Bulgaria 3
EU - Europa 3
GE - Georgia 3
MD - Moldavia 3
PS - Palestinian Territory 3
PY - Paraguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
HN - Honduras 2
IL - Israele 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
LU - Lussemburgo 2
ML - Mali 2
MY - Malesia 2
NO - Norvegia 2
PH - Filippine 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
GR - Grecia 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
LC - Santa Lucia 1
LV - Lettonia 1
MK - Macedonia 1
MU - Mauritius 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TO - Tonga 1
TW - Taiwan 1
Totale 8.815
Salva come PNG Salva come JPEG
Città #
Chandler 476
Singapore 475
Ashburn 262
Warsaw 214
Ann Arbor 123
Jacksonville 114
Beijing 106
Dublin 104
San Mateo 97
Nürnberg 89
Nanjing 85
Wilmington 85
Cattolica 82
New York 80
Los Angeles 76
Jakarta 61
Boston 58
Chicago 54
Dearborn 54
Dallas 50
Munich 46
Houston 43
Fairfield 42
Moscow 40
Woodbridge 40
Ho Chi Minh City 37
Nanchang 36
Lawrence 34
Rome 34
Brussels 33
Frankfurt am Main 33
Hangzhou 33
Redmond 33
Hong Kong 31
Redwood City 31
São Paulo 29
Milan 28
Seattle 28
Izmir 27
Marseille 27
Tokyo 27
Hefei 26
Princeton 25
Hanoi 24
Shanghai 24
Abidjan 22
Boardman 21
Falls Church 20
Mountain View 20
Helsinki 18
London 18
Santa Clara 18
Cambridge 17
Hebei 17
San Francisco 17
Buffalo 16
Guangzhou 16
Johannesburg 16
Can Tho 15
Shenyang 15
Bremen 14
Brooklyn 14
Hyderabad 14
Leawood 14
Changsha 13
Kraków 13
Norwalk 13
Orem 12
Denver 11
Fremont 11
Kent 11
Kunming 11
Phoenix 11
The Dalles 11
Augusta 10
Lancaster 10
Montreal 10
Poplar 10
Rio de Janeiro 10
University Park 10
Amsterdam 9
Chennai 9
Detroit 9
Ankara 8
Atlanta 8
Belo Horizonte 8
Erbil 8
Jiaxing 8
Manchester 8
Simi Valley 8
Toronto 8
Zhengzhou 8
Andover 7
Jinan 7
Kish 7
Mumbai 7
Nuremberg 7
Querétaro 7
Quito 7
Ribeirão Preto 7
Totale 4.210
Salva come PNG Salva come JPEG
Nome #
Chance of cure following liver resection for initially unresectable colorectal metastases: analysis of actual 5-year survival 389
Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy 331
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? 292
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 279
KRAS Early Testing: Consensus Iniziative and Cost-Effectiveness Evaluation for metastatic colerectal patiens in an Italian Setting 246
A phase II study of sunitinib in advanced hepatocellular carcinoma 242
Diagnosis and management of breast lymphoma: A single-institution retrospective analysis 240
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 216
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 209
Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis 204
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 178
Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo 171
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 167
Treatment options of simple bone cysts: the role of bone substitutes, growth factors and literature review 166
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 162
Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-I serum levels in women with breast cancer 155
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 154
Trastuzumab-induced corneal ulceration: successful no-drug treatment of a "blind" side effect in a case report 146
Is surgery mandatory in locally advanced gastrointestinal stromal tumors after imatinib? A case report and literature review. 140
Are TKIs favourable for the elderly with non-small-cell lung cancer? 140
7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study 139
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases 139
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 138
AMAROS Study: Overall Survival in Breast Cancer Subtypes 137
Use of trastuzumab in HER2-positive metastatic breast cancer beyond disease progression: a systematic review of published studies 133
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity 128
Transradial versus Transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study 126
The immune response to tumors as a tool toward immunotherapy 125
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial 124
Advanced colon cancer: staging and prognosis by CEA test 121
Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies 121
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 119
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 116
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 115
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 114
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 111
Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis. 110
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): A randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX 109
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 109
Gas in portal circulation and pneumatosis cystoides intestinalis during chemotherapy for advanced rectal cancer 106
Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: impact of TKIs' antiangiogenic activity. 105
Paradox CA 15-3 increase in metastatic breast cancer patients treated with everolimus: A change of paradigm in a case series 103
Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: A single institution phase II study 102
Targeted Therapy in Advanced Gastric Carcinoma:the Future is Beginning 101
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 100
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 99
Indications for prophylactic osteosynthesis associated with curettage in benign and low-grade malignant primitive bone tumors of the distal femur in adult patients: a case series 94
LUX-Lung 7: is there enough data for a final conclusion? 91
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 89
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 89
Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma: Analysis of REACH Trial Results by Child-Pugh Score 88
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 82
Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis 79
Randomised, placebo-controlled, double-blind, parallele-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer 78
Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer 75
Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse 69
Axitinib or bevacizumab plus FOLFIRI or modified FOLFOX-6 after failure of first-line therapy for metastatic colorectal cancer: a randomized phase II study 69
Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study 69
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer 66
The interference between oxaliplatin & anti-EGFR therapies: A different hypothesis to explain the 'unexplainable' 64
Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC 59
Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial 57
Management of Skin Reactions During Cetuximab Treatment in Association With Chemotherapy or Radiotherapy: Update of the Italian Expert Recommendations 57
Treatment of locally advanced gastric cancer (LAGC): Back to lauren’s classification in pan– cancer analysis era? 56
Multidisciplinary approach for HCC patients: hepatology for the oncologists 55
Soft tissue metastases in lung cancer: a review of the literature 54
New life for retrospective study in the precision oncology era 54
Targeted therapy in advanced gastric carcinoma: The future is beginning 53
Anti-tumour and anti-angiogenetic effects of zoledronic acid on human non-small-cell lung cancer cell line 35
Lung adenocarcinoma presenting as a solitary gingival metastasis: a case report 29
Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy 27
Totale 8.915
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.838
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.838
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021306 0 0 0 0 0 33 69 14 76 28 69 17
2021/2022704 54 44 19 79 49 29 16 108 37 49 80 140
2022/20231.267 182 179 106 226 54 158 64 103 118 25 41 11
2023/2024542 24 162 21 18 15 82 33 42 5 15 51 74
2024/20251.099 25 52 90 53 95 44 47 50 128 111 188 216
2025/20261.945 495 87 200 462 670 31 0 0 0 0 0 0
Totale 8.915